Literature DB >> 19781658

Impending challenges in the hematopoietic stem cell transplantation physician workforce.

James L Gajewski1, C Frederick LeMaistre, Samuel M Silver, Michael C Lill, George B Selby, Mary M Horowitz, J Douglas Rizzo, Helen E Heslop, Claudio Anasetti, Richard T Maziarz.   

Abstract

With increasing use of high dose chemotherapy with autologous and allogeneic transplants the need for the transplant physician workforce requires reassessment. The types of transplants and patients are also shifting toward transplants being done in patients with more comorbidities and more commonly these types of patients require more work effort per patient from the transplant physician. Additionally, HSCT survivors often require ongoing care at the transplant center due to the inability of the primary care workforce or the hematology/oncology workforce to absorb caring for post complex post transplant patients. The adult transplant workforce has had very few physicians join under age 40. Nearly 50% of adult transplant physicians are over age 50 whereas only 28% of pediatric transplant physicians are over age 50. By 2020, it is projected that we will need 1,264 new adult transplant physicians and 94 pediatric transplant physicians. Training time for a physician is approximately 15 years. The capping of both medical school slots and residency slots since the early '80s is now having a very big impact on supply, but other factors are also affecting supplies such as generational differences, lifestyle expectations, and the change of the medical workforce from being mostly men. Workforce shortages are being reported for many specialities. Workforce problems are also present for nurses, pharmacists and medical technologists. So increasing use of general internists and mid-level providers may not exist as a solution. Transplant physicians must be actively engaged in the medical education process to show young medical students and residents who are not committed to another sub specialty career the excitement and challenges of a career in bone marrow transplantation, so that our field will have providers for the future.

Entities:  

Mesh:

Year:  2009        PMID: 19781658     DOI: 10.1016/j.bbmt.2009.08.022

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  9 in total

1.  National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery.

Authors:  Navneet S Majhail; Lih-Wen Mau; Pintip Chitphakdithai; Tammy Payton; Michael Eckrich; Steven Joffe; Stephanie J Lee; Charles F LeMaistre; Jennifer LeRademacher; Fausto Loberiza; Brent Logan; Susan K Parsons; Ramona Repaczki-Jones; Pam Robinett; J Douglas Rizzo; Elizabeth Murphy; Ellen M Denzen
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

2.  Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.

Authors:  Syed O A Ahmed; Ardeshir Ghavamzadeh; Syed Z Zaidi; Helen Baldomero; Marcelo C Pasquini; Fazal Hussain; Kamran Alimoghaddam; Fahad Almohareb; Mouhab Ayas; Amir Hamidieh; Hossam K Mahmoud; Alaa Elhaddad; Tarek Ben Othman; Abdelrahman Abdelkefi; Mahmoud Sarhan; Fawzi Abdel-Rahman; Salman Adil; Salam Alkindi; Ali Bazarbachi; Said Benchekroun; Dietger Niederwieser; Mary Horowitz; Alois Gratwohl; Hassan El Solh; Mahmoud Aljurf
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-01       Impact factor: 5.742

3.  Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field.

Authors:  Evan Shereck; Shalini Shenoy; Michael Pulsipher; Linda Burns; Arthur Bracey; Jeffrey Chell; Edward Snyder; Eneida Nemecek
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-06       Impact factor: 5.742

4.  Prevalence of hematopoietic cell transplant survivors in the United States.

Authors:  Navneet S Majhail; Li Tao; Christopher Bredeson; Stella Davies; Jason Dehn; James L Gajewski; Theresa Hahn; Ann Jakubowski; Steven Joffe; Hillard M Lazarus; Susan K Parsons; Kim Robien; Stephanie J Lee; Karen M Kuntz
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-30       Impact factor: 5.742

5.  Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma.

Authors:  Luciano J Costa; Jia-Xing Huang; Parameswaran N Hari
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-30       Impact factor: 5.742

Review 6.  Allogeneic transplant physician and center capacity in the United States.

Authors:  Navneet S Majhail; Elizabeth A Murphy; Nancy A Omondi; Pam Robinett; James L Gajewski; C Fred LeMaistre; Dennis Confer; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

7.  Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.

Authors:  Karen L Syrjala; Marie-Laure Crouch; Wendy M Leisenring; Mary E D Flowers; Samantha B Artherholt; Allison Stover Fiscalini; Eleni Romano; Joan M Romano; Paul J Martin; Jean C Yi
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-09       Impact factor: 5.742

Review 8.  Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology.

Authors:  M J Rioth; J Warner; B N Savani; M Jagasia
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

Review 9.  Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies.

Authors:  In-Young Jung; Jungmin Lee
Journal:  Mol Cells       Date:  2018-08-14       Impact factor: 5.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.